Tag: EMA

Mitigating Risks of Unreported API Changes during WHO PQ Assessments In the pharmaceutical industry, the integrity of Active Pharmaceutical Ingredients (APIs) is paramount, especially during the WHO Prequalification (PQ) assessments.…

Addressing Unreported API Changes During WHO PQ Assessments: A Practical Playbook In the fast-paced pharmaceutical manufacturing environment, maintaining compliance with WHO prequalification (PQ) standards is crucial for regulatory success. However,…

Navigating PQ Readiness Challenges in Pharmaceutical Manufacturing Manufacturers often face risks when their production sites are not fully ready for PQ assessments during dossier submissions. This situation can significantly impact…

Effective Solutions for Stability Data Gaps During Inspection Readiness for PQ Approval During the preparation for inspections related to WHO Prequalification (PQ) approval, the identification of stability data gaps can…

Strategies to Ensure CAPA Effectiveness and Prevent Suspension During WHO PQ Assessments Manufacturers aiming for WHO Prequalification (PQ) face strict scrutiny that often casts doubt on the effectiveness of Corrective…

Addressing PQ Dossier Deficiencies for Successful Inspection Preparation In today’s pharmaceutical environment, the ability to prepare comprehensively for inspections is paramount. A deficiency in the PQ dossier can compromise not…

Ensuring Manufacturing Sites Are Prepared for PQ Inspections: A Playbook In the pharmaceutical industry, the inability of a manufacturing site to meet prequalification (PQ) standards prior to inspection can lead…

Defending Manufacturing Readiness When Your Site Isn’t PQ-Ready During Dossier Submission Pharmaceutical manufacturers often face stringent regulatory requirements, particularly during WHO Prequalification (PQ) submissions. An alarming finding can be a…

Ensuring CAPA Effectiveness During WHO Prequalification Assessments In the pharmaceutical industry, maintaining high standards of compliance is critical, especially during WHO Prequalification (PQ) assessments. Questions surrounding the effectiveness of Corrective…

Preparing for Inspections When Your Deviation History is Under Scrutiny In the ever-evolving landscape of pharmaceutical manufacturing, the scrutiny of deviation history during inspections poses a substantial challenge. Regulatory authorities…

Preventing Suspension from WHO PQ Due to Unreported API Changes In today’s complex pharmaceutical landscape, companies face the daunting challenge of maintaining compliance with regulatory bodies while managing changes in…

Defending Manufacturing Readiness Against Deviation History Challenges During Requalification In the pharmaceutical industry, maintaining rigorous adherence to Good Manufacturing Practices (GMP) is crucial for ensuring compliance with regulatory requirements. However,…